Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm: interim guidance, first issued 7 May 2021, updated 28 October 2021

28 October 2021
 | Report
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm: interim guidance, first issued 7 May 2021, updated 28 October 2021
Download (287.7 kB)
WHO Team
WHO Headquarters (HQ)
Editors
World Health Organization. Regional Office for Europe
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/BIBP/2021.2
Copyright